Format

Send to

Choose Destination
Hepat Mon. 2018 Oct;18(10). pii: e82345. doi: 10.5812/hepatmon.82345. Epub 2018 Oct 21.

PIB: A Score to Select Sorafenib Treatment Candidates for Hepatocellular Carcinoma in Resource-Limited Settings.

Author information

1
School of Medicine, Vanderbilt University, Nashville, USA.
2
Department of Gastroenterology, Hospital Privado Universitario de Córdoba, Instituto Universitario de Ciencias Biomédicas de Córdoba, Córdoba, Argentina.
3
Centro de Enfermedades Hepaticas y Digestivas (CEHYD), Bogota, Colombia.
4
Department of Gastroenterology, Hospital Clinicas, Buenos Aires, Argentina.
5
Departament of Gastroenterology and Hepatology, Hospital Eugenio Espejo, Quito, Ecuador.
6
Consejo Nacional de Investigaciones Científicas y Técnicas, Posadas, Argentina.
7
Department of Gastroenterology, Hospital Nacional Edgardo Rebagliati Martins (HNERM), Lima, Peru.
8
Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
9
Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil.
10
Department of Gastroenterology, School of Medicine, University of São Paulo, São Paulo, Brazil.

KEYWORDS:

HCC; Hepatocellular Carcinoma; Score; Sorafenib

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center